COMMUNIQUÉS West-GlobeNewswire

Theratechnologies Announces Financial Results for the Third Quarter of 2018
04/10/2018
MONTREAL, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2018. Third quarter 2018 financial highlights [...]
Theratechnologies annonce ses résultats financiers du troisième trimestre de 2018
04/10/2018
MONTRÉAL, 04 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX : TH) a annoncé aujourd’hui ses résultats financiers pour le troisième trimestre clos le 31 août 2018. Faits saillants [...]
Clinical Laserthermia Systems to Exhibit MRI-Guided Laser Thermal Therapy System at 12th Interventional MRI Symposium
04/10/2018
Minimally Invasive, Non-Cooled Laser Fiber Eliminates External Cooling & Helps Reduce Procedure Times FRAMINGHAM, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS Americas [...]
Zafgen to Present Data from Multiple Nonclinical, IND-Enabling Studies of ZGN-1258 at the 2018 Foundation for Prader-Willi Research Family Conference
04/10/2018
Nonclinical data for ZGN-1258 reproduce efficacy seen in first generation candidate for PWS Data show highly improved safety profile Company also presenting study design of PATH for PWS natural history study co- [...]
Cyclacel Pharmaceuticals and MD Anderson Cancer Center Announce Strategic Alliance to Study Novel Cyclacel Medicines in Hematological Malignancies
04/10/2018
Multi-product agreement builds on long-term clinical collaboration in hematological malignancies BERKELEY HEIGHTS, N.J. and HOUSTON, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC, Nasdaq [...]
Landmark AdVance Study Shows Adenovirus Burden Correlates with Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
04/10/2018
– First Study to Show that Adenovirus Area Under the Curve is an Optimal Indicator of Clinical Outcomes in Adenovirus Infection – DURHAM, N.C., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a [...]
PCI Biotech: Final results of the rights issue
04/10/2018
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]
Nightstar Therapeutics to Present at Chardan Genetic Medicines Conference
04/10/2018
WALTHAM, Mass. and LONDON, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced [...]
Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome
04/10/2018
Press release - No. 21/2018 Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome The Phase 3 registration trial has enrolled the first short bowel syndrome ( [...]
FIT Biotech Oy: FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus
04/10/2018
FIT Biotech Oy Company release 04.10.2018 at 11:00 AM EET FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus FIT Biotech Oy ("Company", FITBIO: FN Finland) has filed [...]
Recording of the Second Quarter 2018 Investor Conference Webinar
04/10/2018
On October 3 AS „Olainfarm” organized its Investor Conference Online Webinar. During the webinar the Advisor to the Board of AS „Olainfarm” Salvis Lapiņš analyzed the financial results of second quarter 2018 and [...]
Ambu A/S: Ambu updates 2020 strategy and upgrades financial targets in connection with capital markets day 2018
04/10/2018
One year into the strategy period Ambu is ready to launch four new products and upgrade the long-term financial targets for 2020. Contact Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com [...]
Xbrane Biopharma announces results of in-vivo study showing equivalent tolerability and pharmacokinetic profile of Xlucane compared to Lucentis®
04/10/2018
Press release 2018-10-04 In an in-vivo study involving 16 New Zeeland White rabbits Xlucane (ranibizumab (Lucentis ® ) biosimilar) demonstrated equivalent tolerability and pharmacokinetic profile in the serum and in the [...]
Rule 2.9 Announcement
04/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 October 2018 [...]
Saniona Completes Planned Patient Recruitment for Second Part of Phase 2a Study for Tesomet in Prader-Willi Syndrome
04/10/2018
PRESS RELEASE October 4, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has completed the planned recruitment of adolescents for the second part of its Phase 2a study of [...]
Sandoz Healthcare Access Challenge (HACk) returns, seeking digital solutions to local healthcare access challenges
04/10/2018
Despite major advances in modern medicine, universal access to healthcare remains the largest unmet medical need Building on the inaugural Sandoz HACk, this year's competition expands to seek broader digital solutions [...]
Guardant Health Announces Pricing of Initial Public Offering
04/10/2018
REDWOOD CITY, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH) today announced the pricing of its initial public offering of 12,500,000 shares of common stock at a public offering price of $19 [...]
Amedisys Extends Employment Agreement with CEO Paul Kusserow
03/10/2018
On Heels of Company Turnaround, Will Stay On For Three More Years BATON ROUGE, La., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), America’s leading independent home health, hospice and personal care [...]
Spring Bank Announces Inarigivir Data Presentations at AASLD Conference
03/10/2018
HOPKINTON, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Pages